Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: Primary analysis of the ELM-1 study.
Topp MS, Matasar MJ, Allan JN, Ansell SM, Barnes JA, Arnason JE, Michot JM, Goldschmidt N, O'Brien SM MD, Abadi U, Avivi I, Cheng Y, Flink DM, Zhu M, Brouwer-Visser J, Chaudhry A, Mohamed H, Ambati S, Crombie JL.
Topp MS, et al. Among authors: zhu m.
Blood. 2024 Dec 30:blood.2024027044. doi: 10.1182/blood.2024027044. Online ahead of print.
Blood. 2024.
PMID: 39786390